According to Margetts, Werum’s MES acts as a cockpit for the entire manufacturing process as it controls each and every step of the production and the associated data that must be managed and recorded during the manufacturing process. Upon deploying PAS-X MES into a pharmaceutical factory, the operators, supervisors, and quality department gain instant access to all the necessary information wherever they are through screens and mobile devices. Built in controls such as what has to be produced, at what time and the right authorization of who can do what is ensured ultimately to speed and ease the critical task of releasing important pharma products to the market.

Werum’s MES software is based on “Right First Time and Review by Exception” principles to help users to process the mass of data quickly, to focus and identify issues directly with less resources and a higher level of quality. “Our customers gain huge business benefits such as shorter lead times, secure data entries, efficient equipment management, improved process security, and live monitoring of production by leveraging the MES solution,” says Margetts.

Margetts cites a case-study in Asia where AstraZeneca, a global, science-led biopharmaceutical firm was looking for a solution that could replace their legacy ERP systems and IT solutions. Upon implementing Werum’s PAS-X, AstraZeneca was able to optimize their manufacturing process and reduce the high risks involved in maintaining legacy software in a good manufacturing practice environment. The highly standardized PAS-X MES allowed AstraZeneca to simply configure the systems without any need for custom software development and since its deployment has already extended the MES with our new Pharma 4.0 approaches such as voice recognition and instruction technology that allows for operators to work hands-free with the electronic system whilst still meeting all the special industry regulations.

The future holds even brighter prospects for Werum IT solutions. In terms of new solutions, Werum is en route to releasing the next-generation platforms integrated with the latest powerful Pharma 4.0 initiatives such as Augmented Reality that clients have piloted in commercial manufacturing today. “By delivering robust technology and best practices, we aim to help the pharmaceutical industry operate at world-class levels of performance today, and to win in tomorrow’s digital world,” concludes Margetts.